STOCKTON, CALIFORNIA/ November 9, 2012 /Newswire/ — Viratech, Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the addition of John Stein MD to its Advisory Committee as Head of the Clinical Research Committee for the Company. Dr. John Stein MD has a Master’s Degree in Clinical Research and is an Associate Professor of Emergency Medicine at the University of California San Francisco and has an extensive background in clinical research.
Dr. Stein has been involved in numerous prospective and randomized trials of drug as well as technology implementations in the acute care environment. He received his medical degree from Dartmouth Medical School where he was elected into the Syvertsen Scholarship, received the Merck Manual Award, and graduated in the Alpha Omega Alpha Medical Honors Society. He pursued clinical training at the Alameda County Medical Center’s Highland Hospital, one of the most competitive residency training programs in Emergency Medicine. Since that time he has been on the faculty at UCSF, and has assumed a number of roles aside from research including directing the Emergency Ultrasound Department, and acting as one of the medical school’s eight Advisory College Mentors.
Dr Stein states, “I look forward to assisting Viratech with its many resources and opportunities, including research and working on new ways to improve health care.”
Dr. Stein has recently received a K-08 award from the Agency for Research and Quality which aimed to validate the training guidelines for emergency ultrasound as they pertain to the evaluation of ectopic pregnancy. As part of that four year grant, he completed his Masters in Clinical Research through the university’s clinical and translational sciences institute, and he was also elected to the K Scholars group where he served from 2007-2011.
He has published manuscripts on over 20 prospective trials among a variety of other writings. He also has extensive background with industry and foundation partners, and has received grants from the California Healthcare Foundation as well as the Fujitsu Corporation.
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created a unique biotech research and development platform, leveraging the utility of social collaboration, which is designed to allow cancer research the opportunity for the first time to become open sourced. This will be accomplished by allowing the company’s development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging its social collaboration network, can give the company’s development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in the company’s protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.
Forward-Looking Statements:
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact: Dr. Kevin Buckman
Viratech, Corp.
Email Contact: info@viratech.org